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INTRODUCTION 
In December 2019, several cases of pneumonia presented in Wuhan, China, derived from 
a severe acute respiratory syndrome (SARS) related coronavirus (SARS-CoV-2), named 
coronavirus disease 2019 (COVID-19) by the World Health Organization in February 20201. 
COVID-19 has subsequently been declared a pandemic. According to the Centers for Disease 
Control and Prevention (CDC), as of May 15, the United States has greater than 1.4 million 
confirmed cases and 85,000 deaths2. Globally, a May 15 report from the World Health 
Organization (WHO) stated that approximately 4.3 million COVID-19 cases have been 
identified, and more than 297,000 deaths have occurred related to this infection3. COVID-19 
symptoms include fever, cough, fatigue, pneumonia, and loss of taste. However, the prevalence 
of gastrointestinal symptoms such as nausea, vomiting, and diarrhea in COVID-19 confirmed 
cases have been significant and fecal viral excretion may persist for several weeks after 
resolution of lung illness4. 
During the COVID-19 pandemic, motility laboratories have temporary shut-down, and 
this adjournment provided opportunities for protecting staff and patients from spreading COVID-
19. As of 2019, the United States has more than 120 motility laboratories5. Diagnostic
procedures performed in motility laboratories provide evidence for appropriate intervention for 
gastrointestinal symptoms not explained by structural or mucosal disease. The ANMS organized 
a Task Force for developing guidance strategies regarding re-opening of motility laboratories. 
This document describes how to stratify urgency of motility physiologic procedures, screen prior 
to the procedures, optimize personal protective equipment (PPE) utilization, clean and prepare 
the motility laboratory space during the COVID-19 pandemic. Prioritizing procedures should 
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take into consideration the impact of symptoms on nutrition, need for hospitalization and impact 
on quality of life and well as the role of testing for preoperative evaluation prior to invasive 
procedures, including myotomy, lung transplant, and colectomy. 
The ANMS Task Force recommendations for reactivation of motility laboratory 
operations are based on social guidelines for endoscopic procedures6, taking into consideration 
available evidence as well as expert consensus (Box). However, we encourage all centers and 
health care providers to consult with local and state public health departments, and their 
institution when implementing these recommendations.  
 
The ANMS Task Force recommends the following: 
1. Gastrointestinal motility procedures should be performed in motility laboratories 
adhering to the recommendations and PPE measures described below in order to 
protect patients, ancillary staff and motility allied health professionals. 
2. If available, all patients scheduled for motility procedures should complete a 
COVID-19 test preferably within 48 hours prior to their procedure, as 
recommended by other gastrointestinal societies1. 
a. COVID-19 test results must be documented prior to performing procedures. 
b. If procedures are to be performed without a COVID-19 test, full personal 
protective equipment (PPE) use is recommended, along with all social 
distancing and infection control measures. 
3. Since patients with suspected motility disorders require multiple procedures, 
sequential scheduling of procedures should be considered to minimize need for 
repeat COVID-19 testing.  
4. The strategies for and timing of procedure(s) should be adapted taking into 
consideration local institutional standards, with the provision for heavy screening 
without testing in low prevalence areas. 
5. If tested positive for COVID-19, subsequent negative tests, typically on two 
separate occasions is required prior to scheduling a motility procedure (timing is 
variable). 
6. Specific recommendations for each motility procedure (example, esophageal 
manometry, anorectal manometry or biofeedback therapy) that include triaging, 
indications, PPE use and alternatives for motility procedures are detailed below in 
the document. 




Gastrointestinal motility procedures should only be performed in motility laboratories 
that have capability of adhering to the Task Force recommendations and PPE measures described 
in order to protect patients, ancillary staff and motility allied health professionals. Whenever 
possible, patients scheduled for motility procedures should undergo COVID-19 testing within 48 
hours of the procedure, similar to recommendations for endoscopy as recommended by 
gastroenterology societies6. When multiple motility procedures are indicated, these should be 
scheduled sequentially to obviate the need for repeated COVID-19 testing. Test results should be 
documented in the patient’s record. If tested positive for COVID-19, subsequent negative tests, 
typically on two separate occasions, is required prior to scheduling a motility procedure (timing 
is variable). If institutional and local health authorities recommend against routine COVID-19 
testing prior to routine procedures, pre-procedure symptom screening is imperative, and full PPE 
use are recommended in addition to social distancing and infection control measures.  
Upon arriving at the healthcare facility for the motility laboratory procedure, we endorse 
screening for pertinent COVID-19 symptoms and checking body temperature, even in patients 
with prior negative COVID-19 testing. Patients who screen symptomatic should be rescheduled 
until asymptomatic and re-tested for COVID-19, following similar guidelines used for 
endoscopy and outpatient clinics6. Proper PPE should be worn by individuals performing 
motility laboratory procedures. Table 1 provides recommendations for proper motility laboratory 
PPE requirements. These recommendations are derived from expert opinion and 
gastroenterology society guidelines for endoscopy procedures6. Proper donning and doffing of 
PPE should be practiced to limit spread of potential air-droplets7. 
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PROCEDURE ROOM SET UP 
Adequate spacing is recommended in waiting areas and within motility procedure rooms. 
Strict adherence to scheduled times is recommended to avoid congregation of patients and 
relatives in the waiting areas. This may require patients to wait in their cars rather than at the 
facility if delays are expected, with two-way communication through mobile phones. Only the 
patient should be brought into the procedure room to limit contact between individuals. Adequate 
time should be allowed between procedures to allow for delays, and extra time for terminal 
cleaning of the procedure areas between procedures.  
Consideration can be given for filtering the air within the motility procedure room in 
between each patient whenever possible, as per local institutional standards. If available, this 
could include High-Efficiency Particulate Air (HEPA) filters for prevention of airborne 
infections8. The required time for HEPA filtration is adjusted by the number of exchanges within 
the specific procedure room. Where HEPA filtration is not available, institutional infection 
control measures should be followed.  
Table 1. Recommended Motility Laboratory Personal Protective Equipment (PPE) to Safely 
Perform a Motility Laboratory Procedure 
Motility Laboratory Procedure PPE Recommendations 
Esophageal Physiologic Procedures 
 
N95 mask, double gloves, face shield (and/or 
alternate protective eye wear), and gown 
Antroduodenal Manometry N95 mask, double gloves, face shield, (and/or 
alternate protective eye wear), and gown 
Colon Manometry N95 mask, double gloves, face shield (and/or 
alternate protective eye wear), and gown 
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Wireless Motility Capsule N95 mask, or surgical mask with a face 
shield, gloves, face shield (and/or alternate 
protective eye wear), and gown 
Gastric Emptying Breath Test N95 mask, gloves, face shield (and/or 
alternate protective eye wear), and gown 
Anorectal Structure and Function Testing 
Biofeedback Therapy 
N95 mask or surgical mask with face shield 
(and/or alternate protective eye wear), double 
gloves, and gown 
Hydrogen Breath Testing N95 mask, gloves, face shield (and/or 
alternate protective eye wear), and gown 
 
ESOPHAGEAL PHYSIOLOGIC TESTING 
Esophageal physiologic procedures, including high resolution manometry (HRM), pH- 
and pH-impedance monitoring are typically elective procedures performed in an outpatient 
motility laboratory by trained allied health professional for non-life-threatening indications. 
Accepted indications for testing have not been implemented during the pandemic out of an 
abundance of caution9, 10. Although infrequent, there are limited urgent indications for 
esophageal HRM that deserve attention (Table 2), particularly prior to definitive management of 
achalasia and obstructive motor disorders11. However, alternatives exist, particularly barium 
radiography and functional lumen imaging probe (FLIP) to confirm the diagnosis of achalasia, 
and placement of enteral feeding tubes to maintain nutrition while awaiting definitive 
management. Hiatus hernia repair and anti-reflux surgery is rarely emergent, with the notable 
exception of gastric volvulus, where surgical repair and partial fundoplication can be performed 
without HRM assessment of esophageal peristaltic performance. Wireless prolonged pH 
monitoring can be performed if endoscopy is planned and assessment of reflux burden is 
essential, but this is not anticipated to be an urgent or semi-urgent requirement, except in very 
rare instances. 
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During the pandemic, some semi-urgent procedures have evolved into urgent procedures 
due to prolonged periods of compromised nutrition and the need for time-sensitive management. 
Further, motility will need to balance the back-log of patients that have been cancelled or 
rescheduled with the urgency of the indication as hospitals resume semi-elective and elective 
procedures. Table 2, adapted from a recent publication on the topic11, provides guidance on 
indications and clinical qualifiers that elevate the typically elective esophageal physiologic 
procedures to semi-urgent or emergent status during the COVID-19 crisis. Additionally, this 
table provides a framework that can be used during each phase of the pandemic, including active 
shut-down and recovery as various states and regions of the US are in different stages of 
recovery. 
 
Table 2. Triaging Esophageal Physiologic Procedures 
 Clinical Qualifiers Alternative approach if 
procedure is not available 
Urgent procedures (<2 weeks) 
 
  
HRM in suspected achalasia 
with severe symptoms 
Significant dysphagia with 
inability to maintain hydration and 
nutrition. 
EGD with endotracheal 
intubation and FLIP for 
diagnosis. 
Barium esophagography for 
diagnosis. 
EGD with endotracheal 
intubation and Dobhoff tube or 
gastrostomy tube placement if 
treatment is delayed. 
HRM prior to achalasia 
management  
Plans for urgent management (PD 
or myotomy 
EGD with endotracheal 
intubation and FLIP followed 
by PD. 
EGD with endotracheal 
intubation and FLIP and 
botulinum toxin injection. 
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Barium esophagography for 
diagnosis (if no prior 
confirmation of diagnosis) and 
myotomy referral. 
HRM prior to hernia surgery Large hiatus hernia, risk for 
aspiration or volvulus.  Inability to 
maintain hydration and nutrition. 
 
Barium esophagography for 
diagnosis. 
*Evidence of ischemia- 
emergent surgery 






Dysphagia with weight loss 
(Transition to an urgent HRM 
procedure if nutrition is 
compromised over 2-4 weeks) 
Frequent/daily symptoms 
Impacting quality of life 
Negative endoscopy/barium 
Empiric management with PPI, 
soft/liquid diet 
HRM and Reflux testing Pulmonary status 
Time sensitive procedures for Lung 
Transplant evaluation.  
 
Determined by collaboration 
between pulmonary, surgery 
and gastroenterology 
Elective procedures (> weeks) 
 
  
HRM and Reflux Testing  Dysphagia/Chest Pain without 
weight loss 
Frequent/daily symptoms 
Impacting quality of life 
Negative endoscopy/barium 
Empiric management with PPI, 
soft/liquid diet, esophageal 
muscle relaxants (nitrates or 
calcium channel blockers), 
Neuromodulators  
HRM/reflux monitoring for 
reflux symptoms prior to 
antireflux surgery or with 
incomplete PPI response 
Elective, can be postponed Medical reflux management, 
neuromodulators, lifestyle 
measures 




Elective, can be postponed Remote cognitive and 
behavioural therapy, 
diaphragmatic breathing 
HRM: high resolution manometry; FLIP: functional lumen imaging probe; PD: pneumatic 
dilation; PPI: proton pump inhibitor 
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STOMACH, SMALL INTESTINE, AND COLON 
 
Various diagnostic procedures are used to evaluate motor function in sections of the gut 
from stomach to colon. Two FDA-approved diagnostic modalities, wireless motility capsule 
(WMC) and gastric emptying breath testing (GEBT),can be performed in lieu of gastric 
emptying scintigraphy in patients with symptoms suspicious for gastroparesis12. When 
performed in patients with suspected gastroparesis and/or slow transit constipation, WMC 
generates information on both whole gut and regional gut transit13. This procedure does not 
generate aerosols unless the patient coughs or chokes while swallowing the capsule. Therefore, 
as long as the operator preforming the procedure can socially distance from the patient during 
capsule and meal ingestion while wearing adequate PPE, this procedure should be of low risk to 
the operator.  
Although not as widely available as scintigraphy, GEBT provides a measure of gastric 
emptying by evaluating CO2 excretion in the breath after a 
13C-labeled S platensis enriched meal 
is ingested14. Since breath samples are collected, the test generates aerosols, and could be of risk 
to the operator without adequate protective measures and PPE. In the US, GEBT has been 
predominantly utilized for research and for therapeutic drug trials. Since elective non-COVID 
research is currently halted, and since GEBT carries aerosol-related risks, this will likely only be 
reinstated in late phases of resumption of motility laboratory operations in most institutions. 
Patients with gastric stimulators implanted for management of severe gastroparesis 
through the FDA’s Humanitarian Device Exemption program will need to be seen for symptom 
and device monitoring in outpatient clinics. For patients who present for gastric stimulator 
interrogation, operators and treating physicians will need to follow local guidelines for PPE 
similar to other outpatient encounters, which could include mask, face shield, head cover, gloves, 
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and gown, when adjustments are made to their device. 
Two advanced motility procedures performed in tertiary care centers consist of 
antroduodenal manometry (ADM) to evaluate chronic intestinal pseudo-obstruction (CIPO), and 
colonic manometry to evaluate neurogenic bowel and severe constipation refractory to 
medication15. Both procedures are performed predominantly in the pediatric setting, and not 
routinely in adults.  
For the most part, ADM is an elective procedure, but could be semi-urgent in sick patients 
with suspected small bowel dysmotility. ADM is also recommended for evaluation of small 
bowel dysmotility in severe gastroparesis to triage decision-making prior to enteral feeding 
versus total parenteral nutrition, and in patients with primary or secondary CIPO from either 
neuropathic or myopathic disease prior to multiorgan transplantation. ADM involves placement 
of a manometry catheter using fluoroscopy or EGD, and therefore is an aerosol-generating 
procedure. Therefore, PPE, including N95 mask or equivalent are needed for all staff during 
placement and removal of the ADM catheter. After placement of the catheter, motility recordings 
should be performed in a private area that minimizes broad aerosolization. Patients should wear a 
surgical mask whenever possible. COVID-19 testing prior to ADM is important, since this 
procedure is typically performed in an ambulatory setting, sometimes involving admission to an 
observation unit for prolonged monitoring.  
Colonic manometry is performed for evaluation of neurogenic bowel, and in severe 
constipation to determine presence of colonic dysmotility prior to surgical management, and 
triaging of decision making between medical options and partial/subtotal colectomy. In children, 
it is also performed prior to considering Malone antegrade continence enema (MACE) as 
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treatment for chronic constipation16. Colonic manometry is performed via colonoscopy, and 
since fecal shedding of the coronavirus has been reported7, pre-procedure COVID-19 testing of 
the patient is prudent, and PPE requirements will be similar to society recommendations for 
colonoscopy6.  
Table 3. Triaging Motility Procedures Pertaining to the Stomach, Small Intestine, and Colon 
  
Clinical Qualifiers Alternative approach if 
procedure is not available 
Urgent (<2 weeks)   
None There are no urgent 
indications for antroduodenal 
and colonic manometry 
None 
Semi-Urgent (2-4 weeks)   
Antroduodenal manometry Malnutrition in patient with 
gastroparesis, weight loss, 
severe distension, 
pseudoobstruction, preop for 
multi-visceral small bowel 
transplantation 
CT or MRI enterography 
Small bowel follow through 
Whole gut scintigraphy 
Colonic Manometry Severe constipation 
Suspected neurogenic bowel 
Wireless motility capsule 
(in adults only)  
Radio-opaque marker study 
with KUB x-ray 
Colonic/Whole gut 
scintigraphy 
Elective (>4 weeks)   
Wireless motility capsule 
(WMC) 
Significant constipation not 
optimized with medical 
management, nausea and 
vomiting with negative 
endoscopy  
Prokinetics given empirically 
to treat gastroparesis, 
Optimization of laxatives and 
antiemetics.  
Whole gut scintigraphy 
Gastric emptying study plus 
radiopaque marker studies 
Gastric emptying breath 
testing 
Nausea /vomiting with upper 
abdominal pain (negative 
upper endoscopy) 




ANORECTAL FUNCTION TESTING AND BIO-FEEDBACK THERAPY  
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The anorectal physiologic procedures are routinely performed for the evaluation of 
chronic anorectal diseases including constipation, pelvic floor dysfunction, fecal incontinence 
pre or post-surgical evaluations and levator ani syndrome17. Therefore, indications for these tests 
are typically non-urgent. Additionally, pelvic floor retraining and biofeedback therapy are the 
only evidence-based treatments for anorectal disorders and are generally considered non-urgent, 
although these disorders carry significant morbidity and negatively impact quality of life17. 
Further, many of these disorders remain undiagnosed for years, further adding to the burden of ill 
health and overall health care utilization. We propose measures to adequately care for patients 
without COVID-19 undergoing anorectal physiologic procedures and pelvic biofeedback therapy 
programs, and steps for resuming these operations.  
Scheduling of patients with anorectal and pelvic floor disorders should be based on the 
indications for anorectal physiologic procedures and pelvic biofeedback therapy programs. 
Resources should be prioritized towards patients in whom anorectal manometry and balloon 
expulsion testing will change management strategy and/or triage decision-making for surgery. 
This is particularly important as most facilities anticipate reduced access to motility procedures 
and pelvic biofeedback programs, mostly dictated by the need for extra measures taken to 
mitigate the risk of spread of COVID-19.  
Anorectal physiologic procedures, pelvic floor retraining and biofeedback are considered 
“medium risk” for virus transmission. SARS-CoV-2 shedding in the stool has been reported in 
50-60% of patients, and may take as long as 3-6 weeks to clear after respiratory symptoms 
subside18. Propensity for fecal-oral transmission remains unclear26, although SARS-CoV-2 may 
spread through the aerosolization of feces after flushing. Risk of aerosolization during the  
maneuvers during testing such as cough or forceful breathing is low but can be mitigated by both 
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the patient and the operator wearing masks, and the operator wearing a face shield, gown, hair 
covering and gloves. 
 
Table 4. Triaging Patients for Anorectal Function Testing and Procedures 
 
 
 Clinical Qualifiers Alternative approach if 
procedure is not available 
Urgent (<2 weeks) 
 
  
None There are no urgent 
indications for anorectal 
procedures 
None 
Semi-Urgent (2-4 weeks)   
Prior to surgical management Plan for urgent surgery  Defecography 
Anorectal Manometry and 
Balloon Expulsion Testing  
Endoanal Ultrasound 
Fecal impaction 
Severe constipation and 
inability to pass stool 
Large volumes enemas, 
Hypaque enema, Endoscopic 
disimpaction 
Anorectal Manometry  Anorectal pain 
Significant pelvic/rectal pain, 
Negative impact on quality 
of life 
Medical management  
Elective (>4 weeks)   
Anorectal Manometry and 
Balloon Expulsion Test, 




Significant constipation not 
optimized with medical 
management, Negative 
impact on quality of life 
Lifestyle modifications, 
Medical laxative 
management, Squatting stool, 
Diaphragmatic breathing 
Anorectal Manometry  
Endoanal Ultrasound, 
TAMS or Neuropathy or 
EMG Test, Pelvic floor 




Significant incontinence of 
stool not optimized with fiber 
and medical management, 
Negative impact on quality 
of life 
Lifestyle modification, 
Medical management to 
optimize stool consistency, 
Kegel Exercises  
Anorectal Manometry, 
Pelvic floor retraining and 
Biofeedback Therapy  
Anorectal Pain 
Significant pain suggestive of 
levator ani syndrome 
Conservative medical 
management  
Anorectal Manometry and 
Balloon Expulsion Test  
(Pre or Post-pouch surgery 
Or Colectomy surgery) 
Patients who have undergone 
pouch surgery requiring re-
anastomosis or those being 
considered for pouch surgery 
or severe constipation and 
consideration of colectomy 
Conservative medical 
management 
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and ileostomy versus ileo-
rectal anastomosis 
TAMS= Translumbosacral anorectal magnetic stimulation test.  
 
HYDROGEN BREATH TESTING 
Breath testing can be a valuable adjunct to identify patients with small intestinal bacterial 
overgrowth (SIBO) or carbohydrate malabsorption. For SIBO, breath tests using glucose or 
lactulose are commonly used. Each of these tests has its strengths and weaknesses. Most agree 
that lactulose is likely to be the more sensitive of the two options, but glucose is likely to be the 
more specific testing substrate19. Breath testing can also be used to identify patients with lactose, 
fructose or sucrose malabsorption.  Protocols for conducting breath tests can be found in the 
Rome consensus document20 and the North American Consensus document21. For the most part, 
breath tests should be considered elective procedures. There are several alternative means by 
which to diagnose SIBO or carbohydrate malabsorption (see table). SIBO can be diagnosed with 
small bowel aspiration for quantitative culture19. Patients with a high pretest probability of SIBO 
such as those with scleroderma, diabetes with autonomic neuropathy, gastric or small bowel 
surgery, radiation enteritis, to name a few, may not need testing before offering a course of 
antibiotics. Disaccharidase deficiency (lactase, sucrase isomaltase) can be identified with small 
bowel biopsy and quantitative disaccharidase enzyme assay22. Oral enzyme replacement therapy 
is available for lactase and sucrase. A clinician can attempt a trial with substrate (sucrose, 
lactose, fructose) restriction or challenge. There are also blood tests for gene variants which 
identify patients with congenital forms of hypolactasia or sucrase-isomaltase deficiency. As 
breath testing is considered an aerosol generating procedure, patients should have a negative 
COVID-19 test before their procedure. Ideally, patients with a positive test should be 
rescheduled to a later date. In circumstances where patients do not undergo pre-procedure 
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COVID testing, the patient should be delayed allowing for COVID testing or managed by staff 
with full personal protective equipment including an N95 mask. At home breath testing, offered 
by several commercial vendors, is an alternative to traditional laboratory-based breath testing. 
This option may be attractive to practices which do not otherwise perform breath testing or in 
circumstances where COVID testing is not readily available or in which a patient resides far 
from their physician’s facilities.   
 
Table 5. Triaging Patients Needing Hydrogen Breath Testing 
  
Clinical Qualifiers Alternative approach if 
procedure is not available 
Urgent (< 2weeks) There are no urgent 
indications for hydrogen 
breath testing 
 
None   
Semi-Urgent (2-4 weeks)   
None There are no semi-urgent 
indications for hydrogen 
breath testing 
 
Elective (>4 weeks)   
Breath testing for SIBO 
(glucose, lactulose) 
Breath testing for CHO 
malabsorption (lactose, 
fructose, sucrose) 
With rare exception, breath 
tests are elective.  
SIBO – empiric trial of 
antibiotics, small bowel 




(lactose, sucrase isomaltase) 
can be diagnosed with small 
bowel biopsy and 
disaccharidase assay.  
Trial of an exclusion diet, 
substrate challenge, or 
enzyme replacement therapy.  
Blood testing for gene 
variants can identify patients 
with congenital forms of 
hypolactasia or sucrase-
isomaltase deficiency  
 
Baker et al 16 
 
PEDIATRIC MOTILITY TESTING 
Pediatric motility procedures includes mainly 5 types of physiologic tests: 1) Esophageal 
physiologic procedures, including esophageal manometry (water perfused and high resolution 
manometry (HRM) with and without impedance, pH and pH impedance monitoring systems, 2) 
Antroduodenal manometry, 3) Colonic manometry, 4) Anorectal manometry, and 5) Hydrogen 
and Lactose breath tests. These procedures are typically considered elective and performed in an 
outpatient motility laboratory by allied health professionals and physician motility experts. 
Alternatives include radiological studies such as esophagram, upper gastrointestinal series, small 
bowel follow through and barium enema.  Urgent/emergent indications are rare for these 
procedures in pediatrics, other than for achalasia and for the rare patient who needs assessment 
of gut motility prior to surgical treatment. For institutions that have FLIP available, this can be 
an alternative for confirmation of achalasia, and precautions are the same as for upper 
endoscopy6. The risks that each of these procedures carry, and the precautions needed are the 
same as in the adult setting.  
Table 6. Triaging Pediatric Patients for Motility Procedures 
 
Clinical Qualifiers Alternative approach if 
procedure is not available 
Urgent (<2 weeks)   
Esophageal high resolution 
manometry/ impedance in 
suspected Achalasia 
Dysphagia, chest pain, 
vomiting, weight loss, 
inability to maintain 
hydration 
Esophagram, EGD and FLIP 
for diagnosis, pneumatic 
balloon dilatation for 
achalasia treatment 
Semi-Urgent (2-4 weeks) 
 
A 
Esophageal high resolution  
manometry/impedance in 
suspected Achalasia 
Dysphagia, chest pain, 
vomiting but WITHOUT 
weight loss, and able to 
maintain hydration and 
nutrition  
 Esophagram, EGD and FLIP 
for diagnosis, pneumatic 
balloon dilation for treatment 
Antroduodenal manometry Chronic vomiting and nausea, 
abdominal distention, 
Upper GI series with small 
bowel follow through, CT 
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abdominal pain, pseudo-
obstruction, weight loss, 
inability to maintain nutrition 
or hydration, inpatient, TPN 
dependent, possible surgical 
intervention needed 
scan or MR enterography, 
whole gut scintigraphy, 
bowel rest, NG suction, 
empiric treatment for SIBO, 
prokinetics, enteral nutrition, 
TPN 





chest pain, supragastric 




empiric treatment with PPIs, 
prokinetics, soft 
mechanical/liquid diet 
Antroduodenal manometry  Chronic vomiting and nausea, 
abdominal distention, 
abdominal pain, WITHOUT 
weight loss, able to maintain 
hydration and nutrition, not 
TPN dependent and not a 
surgical patient 
Upper Gastrointestinal series 
with small bowel follow 
through, CT scan, MRI 
enterogrpahy, whole gut 
scintigraphy, empiric 
treatment for SIBO, empiric 
treatment with PPI, 
prokinetics, enteral feeds 
Colonic manometry Chronic constipation, 
abdominal distention and 
dilated colon 
Barium enema, treatment 
with stimulant laxatives and 
stool softeners, transanal 
irrigations 
Anorectal manometry Chronic constipation, fecal 
incontinence, abdominal 
distention,  pelvic floor 
dyssynergia 
Barium enema, treatment 
with stimulant laxatives and 
stool softeners, transanal 
irrigations, pelvic floor 
physical therapy, behavior 
modification and counselling 
Breath tests Abdominal bloating and 
distention, abdominal pain, 
suspected SIBO, suspected 
lactose intolerance 
Empiric treatment with 
lactose free diet. Empiric 
treatment with antibiotics for 
SIBO  
EGD: Esophagogastroduodenoscopy; FLIP: Endo FLIP; SIBO; Small bowel bacterial 
overgrowth; NG: Naso-gastric; UGI series: Upper Gastrointestinal series 
 
BILLING FOR MOTILITY TESTING RELATIVE TO COVID-19 
During the COVID-19 pandemic, we anticipate that many gastrointestinal physiology and 
motility laboratories will face significant financial challenges. We recommend that physicians 
involved in leadership of motility laboratories become familiar with methods to optimize 
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reimbursement for the procedures performed. A recent review provided a comprehensive outline 
of CPT codes for gastrointestinal physiology and motility procedures in the year 2020, along 
with important reimbursement suggestions5. Additionally, the ANMS commissioned a billing 
and coding update specific to esophageal function testing in 201823. These are useful resources 
for motility laboratories. 
The Centers for Medicare & Medicaid Services (CMS) has greatly expanded the 
coverage for telehealth, including audio-only evaluations amid this pandemic24. We recommend 
that clinicians managing gastrointestinal motility disorders and leaders of motility laboratories 
remain current with evolving telehealth opportunities across insurers. During the upcoming 
months, gastrointestinal physiology and motility procedures may be postponed, or alternative 
tests may be recommended, which will often require detailed discussion with each patient 
regarding options and ongoing management. Specifically, for hydrogen and methane breath 
testing, practitioners may opt to pursue home testing for their patients, which could shift motility 
laboratory revenue to the entity reporting home testing results. A telehealth visit explaining the 
appropriate methods for home breath testing, interpretation of testing, and explaining 
management recommendations may provide an opportunity for the motility laboratory to engage 
with the patient. Overall, all providers should continue to interact with their patients and follow 
safely guidelines when performing motility-related procedures. 
 
CONCLUSION 
As health care professionals return to their medical offices and resume operations, 
rescheduling of patients for elective gastrointestinal motility procedures is being considered, and 
safety of staff, patients and family members is of paramount importance. We present a 
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framework based on stratification of motility procedure indications to urgent, semi-urgent and 
elective, using clinical qualifiers and alternatives to the primary procedure to make appropriate 
testing decisions. The re-activation timeline will need to be based on individual institutional 
policies. The ANMS task force acknowledges that these expert recommendations may need to be 
modified as the COVID-19 pandemic evolves, and new data becomes available once motility 
laboratories reopen. Careful monitoring of resurgence will likely also impact future policies and 
recommendations. Evolving information may result in either loosening or tightening of re-
activation measures, depending on whether peaks or surges of COVID-19 cases re-occur. 
Recommendations may also change depending on exposure risks in individual institutions and 
regions, and further monitoring of outcome of patients presenting for motility laboratory 
procedures.  
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